Humoral and cellular responses to the third COVID-19 BNT162b2 vaccine dose in research institute workers in Japan

被引：0
|
作者：
Nishikimi, Akihiko [1 ]
Nakagawa, Takeshi [2 ]
Fujiwara, Mitsuhiro [1 ,3 ]
Watanabe, Ken [4 ,5 ]
Watanabe, Atsushi [6 ]
Komatsu, Ayane [2 ]
Yasuoka, Mikako [7 ]
Watanabe, Ryota [7 ]
Naya, Masahiro [8 ]
Oshima, Hironori [8 ]
Kitagawa, Yuichi [9 ]
Tokuda, Haruhiko [4 ,8 ]
Kondo, Izumi [10 ]
Niida, Shumpei [11 ]
Sakurai, Takashi [11 ]
Kojima, Masayo [7 ]
Arai, Hidenori [10 ]
机构：
[1] Natl Ctr Geriatr & Gerontol, Res Inst, Biosafety Adm Div, 7-430 Morioka, Obu, Aichi 4748511, Japan
[2] Natl Ctr Geriatr & Gerontol, Res Inst, Dept Social Sci, Obu, Aichi, Japan
[3] Toyohashi SOZO Univ, Sch Hlth Sci, Dept Phys Therapy, Obu, Aichi, Japan
[4] Natl Ctr Geriatr & Gerontol, Res Inst, Bioresource Div, Obu, Aichi, Japan
[5] Natl Ctr Geriatr & Gerontol, Res Inst, Dept Musculoskeletal Dis, Obu, Aichi, Japan
[6] Natl Ctr Geriatr & Gerontol, Res Inst, Equipment Management Div, Obu, Aichi, Japan
[7] Natl Ctr Geriatr & Gerontol, Res Inst, Dept Frailty Res, Obu, Aichi, Japan
[8] Natl Ctr Geriatr & Gerontol, Dept Clin Lab, Obu, Aichi, Japan
[9] Natl Ctr Geriatr & Gerontol, Dept Infect Control, Obu, Aichi, Japan
[10] Natl Ctr Geriatr & Gerontol, Obu, Aichi, Japan
[11] Natl Ctr Geriatr & Gerontol, Res Inst, Obu, Aichi, Japan
来源：
JOURNAL OF INFECTION | 2023年 / 86卷 / 02期
关键词：
D O I：
10.1016/j.jinf.2022.10.026
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：E33 / E35
页数：3
相关论文
共 50 条
  • [1] Cellular and Humoral Immune Response to a Third Dose of BNT162b2 COVID-19 Vaccine - A Prospective Observational Study
    Herzberg, Jonas
    Fischer, Bastian
    Becher, Heiko
    Becker, Ann-Kristin
    Honarpisheh, Human
    Guraya, Salman Yousuf
    Strate, Tim
    Knabbe, Cornelius
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [2] Humoral Response to the Third Dose of BNT162b2 COVID-19 Vaccine among Hemodialysis Patients
    Agur, Timna
    Zingerman, Boris
    Ben-Dor, Naomi
    Alkeesh, Weaam
    Steinmetz, Tali
    Rachamimov, Ruth
    Korzets, Asher
    Rozen-Zvi, Benaya
    Herman-Edelstein, Michal
    NEPHRON, 2023, 147 (3-4) : 185 - 192
  • [3] Safety and Efficacy of a Third Dose of BNT162b2 Covid-19 Vaccine
    Moreira, Edson D., Jr.
    Kitchin, Nicholas
    Xu, Xia
    Dychter, Samuel S.
    Lockhart, Stephen
    Gurtman, Alejandra
    Perez, John L.
    Zerbini, Cristiano
    Dever, Michael E.
    Jennings, Timothy W.
    Brandon, Donald M.
    Cannon, Kevin D.
    Koren, Michael J.
    Denham, Douglas S.
    Berhe, Mezgebe
    Fitz-Patrick, David
    Hammitt, Laura L.
    Klein, Nicola P.
    Nell, Haylene
    Keep, Georgina
    Wang, Xingbin
    Koury, Kenneth
    Swanson, Kena A.
    Cooper, David
    Lu, Claire
    Tuereci, Oezlem
    Lagkadinou, Eleni
    Tresnan, Dina B.
    Dormitzer, Philip R.
    Sahin, Ugur
    Gruber, William C.
    Jansen, Kathrin U.
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (20): : 1910 - 1921
  • [4] Cellular and humoral response to the fourth BNT162b2 mRNA COVID-19 vaccine dose in patients with CLL
    Benjamini, Ohad
    Gershon, Rotem
    Bar-Haim, Erez
    Lustig, Yaniv
    Cohen, Hila
    Doolman, Ram
    Kedmi, Meirav
    Ribakovsky, Elena
    Kneller, Abraham
    Hod, Tammy
    Erez, Noam
    Levy, Itzhak
    Rahav, Galia
    Avigdor, Abraham
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2023, 110 (01) : 99 - 108
  • [5] Waning effectiveness of the third dose of the BNT162b2 mRNA COVID-19 vaccine
    Tal Patalon
    Yaki Saciuk
    Asaf Peretz
    Galit Perez
    Yoav Lurie
    Yasmin Maor
    Sivan Gazit
    Nature Communications, 13
  • [6] Acute myocarditis after a third dose of the BNT162b2 COVID-19 vaccine
    Fosch, Xavier
    Serra, Julia
    Torres, Pedro L.
    Preda, Luminita
    Gonzalez, Rosa
    Mojer, Francisca
    REVISTA ESPANOLA DE CARDIOLOGIA, 2022, 75 (07): : 614 - 616
  • [7] Waning effectiveness of the third dose of the BNT162b2 mRNA COVID-19 vaccine
    Patalon, Tal
    Saciuk, Yaki
    Peretz, Asaf
    Perez, Galit
    Lurie, Yoav
    Maor, Yasmin
    Gazit, Sivan
    NATURE COMMUNICATIONS, 2022, 13 (01)
  • [8] BNT162b2 COVID-19 vaccine
    不详
    AUSTRALIAN PRESCRIBER, 2021, 44 (02) : 57 - 58
  • [9] Immune responses to COVID-19 vaccine BNT162b2 in workers at a research institute in Japan: 6-month follow-up survey
    Nishikimi, Akihiko
    Watanabe, Ken
    Watanabe, Atsushi
    Yasuoka, Mikako
    Watanabe, Ryota
    Fujiwara, Mitsuhiro
    Oshima, Hironori
    Nakagawa, Takeshi
    Kitagawa, Yuichi
    Tokuda, Haruhiko
    Washimi, Yukihiko
    Niida, Shumpei
    Kojima, Masayo
    JOURNAL OF INFECTION, 2022, 85 (02) : 174 - 176
  • [10] Fourth Dose of BNT162b2 mRNA Covid-19 Vaccine
    Tumminia, Andrea
    Romano, Marcello
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (02): : 191 - 191
12345